MOUNT VERNON — Skin tests for exposure to tuberculosis are currently being limited to priority risk groups, due to a recently announced shortage of the product Tubersol.
Manufactured by Sanofi Pasteur Limited, Tubersol is a Tuberculin Purified Protein derivative used for intradermal injection in TB tests. Jackie Fletcher, director of Child and Community Health Services at the Knox County Health Department, told the News that while there remains a shortage of Tubersol, skin tests are recommended to be limited to those in priority groups until the product is replenished.
For the rest of the story
The rest of this article is available to Mount Vernon News subscribers. To continue reading, please log in or purchase a subscription. Click here for the April 17, 2013 e-edition. The article will only be available for thirty (30) days.
Contact Alan ReedEmail
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.